LOS ANGELES, United States:The report is an all-inclusive research study of the global Interferon market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Interferon market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Interferon report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) :https://www.qyresearch.com/sample-form/form/1638467/global-interferon-market
In addition, market revenues based on region and country are provided in the Interferon report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Interferon market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Interferon market are mapped by the report. With the help of this report, the key players of the global Interferon market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.
Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Interferon market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Interferon market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.
Key Players Mentioned in the Global Interferon Market Research Report: Roche, Anke Biotechnology, Bayer, Merck & Co, Tri-Prime, Kawin, Genzon Pharma, Novartis, Biogen, Merck KGaA, Zydus Cadila, Huaxin Biotechnology, Harbin Pharmaceutical
Global Interferon Market Segmentation by Product: Assay Kit, Analyzer
Global Interferon Market Segmentation by Application: , Hepatitis, Multiple Sclerosis, Others
The Interferon Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Interferon market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Interferon market and its potential to grow in the years to come.
Key questions answered in the report:
Request for customization in Report:https://www.qyresearch.com/customize-request/form/1638467/global-interferon-market
Table of Contents:
1 Interferon Market Overview1.1 Interferon Product Overview1.2 Interferon Market Segment by Type1.2.1 Long-lasting Type1.2.2 Ordinary Type1.3 Global Interferon Market Size by Type (2015-2026)1.3.1 Global Interferon Market Size Overview by Type (2015-2026)1.3.2 Global Interferon Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Interferon Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Interferon Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Interferon Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Interferon Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Interferon Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Interferon Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Interferon Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Interferon Sales Breakdown by Type (2015-2026)1.4.2 Europe Interferon Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Interferon Sales Breakdown by Type (2015-2026)1.4.4 Latin America Interferon Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Interferon Sales Breakdown by Type (2015-2026)1.5 Coronavirus Disease 2019 (Covid-19): Interferon Industry Impact1.5.1 How the Covid-19 is Affecting the Interferon Industry
1.5.1.1 Interferon Business Impact Assessment Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Interferon Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Interferon Players to Combat Covid-19 Impact 2 Global Interferon Market Competition by Company2.1 Global Top Players by Interferon Sales (2015-2020)2.2 Global Top Players by Interferon Revenue (2015-2020)2.3 Global Top Players Interferon Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Interferon Manufacturing Base Distribution, Sales Area, Product Type2.5 Interferon Market Competitive Situation and Trends2.5.1 Interferon Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Interferon Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon as of 2019)2.7 Date of Key Manufacturers Enter into Interferon Market2.8 Key Manufacturers Interferon Product Offered2.9 Mergers & Acquisitions, Expansion 3 Global Interferon Status and Outlook by Region (2015-2026)3.1 Global Interferon Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Interferon Market Size Market Share by Region (2015-2020)3.2.1 Global Interferon Sales Market Share by Region (2015-2020)3.2.2 Global Interferon Revenue Market Share by Region (2015-2020)3.2.3 Global Interferon Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Interferon Market Size Market Share by Region (2021-2026)3.3.1 Global Interferon Sales Market Share by Region (2021-2026)3.3.2 Global Interferon Revenue Market Share by Region (2021-2026)3.3.3 Global Interferon Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Interferon Market Size YoY Growth (2015-2026)3.4.1 North America Interferon Revenue YoY Growth (2015-2026)3.4.2 North America Interferon Sales YoY Growth (2015-2026)3.5 Asia-Pacific Interferon Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Interferon Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Interferon Sales YoY Growth (2015-2026)3.6 Europe Interferon Market Size YoY Growth (2015-2026)3.6.1 Europe Interferon Revenue YoY Growth (2015-2026)3.6.2 Europe Interferon Sales YoY Growth (2015-2026)3.7 Latin America Interferon Market Size YoY Growth (2015-2026)3.7.1 Latin America Interferon Revenue YoY Growth (2015-2026)3.7.2 Latin America Interferon Sales YoY Growth (2015-2026)3.8 Middle East and Africa Interferon Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Interferon Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Interferon Sales YoY Growth (2015-2026) 4 Global Interferon by Application4.1 Interferon Segment by Application4.1.1 Hepatitis4.1.2 Multiple Sclerosis4.1.3 Others4.2 Global Interferon Sales by Application: 2015 VS 2020 VS 20264.3 Global Interferon Historic Sales by Application (2015-2020)4.4 Global Interferon Forecasted Sales by Application (2021-2026)4.5 Key Regions Interferon Market Size by Application4.5.1 North America Interferon by Application4.5.2 Europe Interferon by Application4.5.3 Asia-Pacific Interferon by Application4.5.4 Latin America Interferon by Application4.5.5 Middle East and Africa Interferon by Application 5 North America Interferon Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Interferon Sales Market Share by Country (2015-2020)5.1.2 North America Interferon Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Interferon Sales Market Share by Country (2021-2026)5.2.2 North America Interferon Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Interferon Market Size YoY Growth (2015-2026)5.3.2 Canada Interferon Market Size YoY Growth (2015-2026) 6 Europe Interferon Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Interferon Sales Market Share by Country (2015-2020)6.1.2 Europe Interferon Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Interferon Sales Market Share by Country (2021-2026)6.2.2 Europe Interferon Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Interferon Market Size YoY Growth (2015-2026)6.3.2 France Interferon Market Size YoY Growth (2015-2026)6.3.3 U.K. Interferon Market Size YoY Growth (2015-2026)6.3.4 Italy Interferon Market Size YoY Growth (2015-2026)6.3.5 Russia Interferon Market Size YoY Growth (2015-2026) 7 Asia-Pacific Interferon Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Interferon Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Interferon Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Interferon Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Interferon Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Interferon Market Size YoY Growth (2015-2026)7.3.2 Japan Interferon Market Size YoY Growth (2015-2026)7.3.3 South Korea Interferon Market Size YoY Growth (2015-2026)7.3.4 India Interferon Market Size YoY Growth (2015-2026)7.3.5 Australia Interferon Market Size YoY Growth (2015-2026)7.3.6 Taiwan Interferon Market Size YoY Growth (2015-2026)7.3.7 Indonesia Interferon Market Size YoY Growth (2015-2026)7.3.8 Thailand Interferon Market Size YoY Growth (2015-2026)7.3.9 Malaysia Interferon Market Size YoY Growth (2015-2026)7.3.10 Philippines Interferon Market Size YoY Growth (2015-2026)7.3.11 Vietnam Interferon Market Size YoY Growth (2015-2026) 8 Latin America Interferon Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Interferon Sales Market Share by Country (2015-2020)8.1.2 Latin America Interferon Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Interferon Sales Market Share by Country (2021-2026)8.2.2 Latin America Interferon Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Interferon Market Size YoY Growth (2015-2026)8.3.2 Brazil Interferon Market Size YoY Growth (2015-2026)8.3.3 Argentina Interferon Market Size YoY Growth (2015-2026) 9 Middle East and Africa Interferon Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Interferon Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Interferon Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Interferon Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Interferon Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Interferon Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Interferon Market Size YoY Growth (2015-2026)9.3.3 UAE Interferon Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Interferon Business10.1 Roche10.1.1 Roche Corporation Information10.1.2 Roche Description, Business Overview and Total Revenue10.1.3 Roche Interferon Sales, Revenue and Gross Margin (2015-2020)10.1.4 Roche Interferon Products Offered10.1.5 Roche Recent Development10.2 Anke Biotechnology10.2.1 Anke Biotechnology Corporation Information10.2.2 Anke Biotechnology Description, Business Overview and Total Revenue10.2.3 Anke Biotechnology Interferon Sales, Revenue and Gross Margin (2015-2020)10.2.4 Roche Interferon Products Offered10.2.5 Anke Biotechnology Recent Development10.3 Bayer10.3.1 Bayer Corporation Information10.3.2 Bayer Description, Business Overview and Total Revenue10.3.3 Bayer Interferon Sales, Revenue and Gross Margin (2015-2020)10.3.4 Bayer Interferon Products Offered10.3.5 Bayer Recent Development10.4 Merck & Co10.4.1 Merck & Co Corporation Information10.4.2 Merck & Co Description, Business Overview and Total Revenue10.4.3 Merck & Co Interferon Sales, Revenue and Gross Margin (2015-2020)10.4.4 Merck & Co Interferon Products Offered10.4.5 Merck & Co Recent Development10.5 Tri-Prime10.5.1 Tri-Prime Corporation Information10.5.2 Tri-Prime Description, Business Overview and Total Revenue10.5.3 Tri-Prime Interferon Sales, Revenue and Gross Margin (2015-2020)10.5.4 Tri-Prime Interferon Products Offered10.5.5 Tri-Prime Recent Development10.6 Kawin10.6.1 Kawin Corporation Information10.6.2 Kawin Description, Business Overview and Total Revenue10.6.3 Kawin Interferon Sales, Revenue and Gross Margin (2015-2020)10.6.4 Kawin Interferon Products Offered10.6.5 Kawin Recent Development10.7 Genzon Pharma10.7.1 Genzon Pharma Corporation Information10.7.2 Genzon Pharma Description, Business Overview and Total Revenue10.7.3 Genzon Pharma Interferon Sales, Revenue and Gross Margin (2015-2020)10.7.4 Genzon Pharma Interferon Products Offered10.7.5 Genzon Pharma Recent Development10.8 Novartis10.8.1 Novartis Corporation Information10.8.2 Novartis Description, Business Overview and Total Revenue10.8.3 Novartis Interferon Sales, Revenue and Gross Margin (2015-2020)10.8.4 Novartis Interferon Products Offered10.8.5 Novartis Recent Development10.9 Biogen10.9.1 Biogen Corporation Information10.9.2 Biogen Description, Business Overview and Total Revenue10.9.3 Biogen Interferon Sales, Revenue and Gross Margin (2015-2020)10.9.4 Biogen Interferon Products Offered10.9.5 Biogen Recent Development10.10 Merck KGaA10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Interferon Product Category, Application and Specification10.10.3 Merck KGaA Interferon Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Merck KGaA Recent Development10.11 Zydus Cadila10.11.1 Zydus Cadila Corporation Information10.11.2 Zydus Cadila Description, Business Overview and Total Revenue10.11.3 Zydus Cadila Interferon Sales, Revenue and Gross Margin (2015-2020)10.11.4 Zydus Cadila Interferon Products Offered10.11.5 Zydus Cadila Recent Development10.12 Huaxin Biotechnology10.12.1 Huaxin Biotechnology Corporation Information10.12.2 Huaxin Biotechnology Description, Business Overview and Total Revenue10.12.3 Huaxin Biotechnology Interferon Sales, Revenue and Gross Margin (2015-2020)10.12.4 Huaxin Biotechnology Interferon Products Offered10.12.5 Huaxin Biotechnology Recent Development10.13 Harbin Pharmaceutical10.13.1 Harbin Pharmaceutical Corporation Information10.13.2 Harbin Pharmaceutical Description, Business Overview and Total Revenue10.13.3 Harbin Pharmaceutical Interferon Sales, Revenue and Gross Margin (2015-2020)10.13.4 Harbin Pharmaceutical Interferon Products Offered10.13.5 Harbin Pharmaceutical Recent Development 11 Interferon Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Interferon Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Interferon Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.
See original here:
Interferon Market Growth, Projections, Analysis, Trends and Forecast 2026 | ( Roche, Anke Biotechnology, Bayer) - The Daily Chronicle
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022
- Where Does Veru Inc (VERU) Stock Fall in the Biotechnology Field After It Is Down -59.36% This Week? - InvestorsObserver - November 17th, 2022
- Should Biotechnology Stock LogicBio Therapeutics Inc (LOGC) Be in Your Portfolio Tuesday? - InvestorsObserver - November 17th, 2022
- PDS BIOTECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - Marketscreener.com - November 17th, 2022
- Biotechnology Industrial Training Program Winter Edition By Startup Incubation and Innovation Centre IIT Kanpur - BioTecNika - November 17th, 2022
- Where Does Axsome Therapeutics Inc (AXSM) Stock Fall in the Biotechnology Field After It Is Lower By -1.80% This Week? - InvestorsObserver - November 17th, 2022
- Where Does CTI BioPharma Corp (CTIC) Stock Fall in the Biotechnology Field After It Is Higher By 3.33% This Week? - InvestorsObserver - November 7th, 2022
- VIR BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - November 7th, 2022
- Is Syndax Pharmaceuticals Inc (SNDX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 7th, 2022
- An Introduction to Biotechnology - PMC - PubMed Central (PMC) - October 31st, 2022
- Biotechnology, M.S. | Florida Tech - FIT - October 31st, 2022
- What is Biotech? Types of Biotech + More | Built In - October 31st, 2022
- Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022... - October 31st, 2022
- Where Does Sorrento Therapeutics Inc (SRNE) Stock Fall in the Biotechnology Field After It Is Up 6.58% This Week? - InvestorsObserver - October 31st, 2022
- Where Does Veru Inc (VERU) Stock Fall in the Biotechnology Field After It Is Lower By -5.84% This Week? - InvestorsObserver - October 31st, 2022
- Zero emission vehicles: first Fit for 55 deal will end the sale of new CO2 emitting cars in Europ... - Modern Diplomacy - October 31st, 2022
- The Worldwide Biotechnology Industry is Expected to Reach $2234 Billion by 2027 - ResearchAndMarkets.com - Business Wire - September 29th, 2022
- Argentina: Promotion of modern biotechnology and nanotechnology - Lexology - September 29th, 2022
- Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors - GlobeNewswire - September 29th, 2022
- CIA Just Invested In Woolly Mammoth Resurrection Tech - The Intercept - September 29th, 2022
- Vir Biotechnology Announces First Patient Dosed in the Phase 2 SOLSTICE Trial Evaluating VIR-2218 and VIR-3434 for the Treatment of Chronic Hepatitis... - September 29th, 2022
- Viewpoint: Will King Charles abandon his kooky ideas about agriculture and help accelerate Britain's embrace of sustainable biotechnology tools? -... - September 29th, 2022
- Top Biotechnology Stocks to Buy in 2022 - Best Stocks - September 29th, 2022
- Biotechnology investing for the social good making money and a difference - Stockhead - September 29th, 2022
- Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit - GlobeNewswire - September 29th, 2022
- Fact Sheet - HHS.gov - September 20th, 2022
- Deputy Secretary of Defense Dr. Kathleen Hicks' Remarks at the White House Summit on Biote - Department of Defense - September 20th, 2022